Immunic, Inc. to Participate in Investor Conference in December ...Middle East

PR Newswire - News
Immunic, Inc. to Participate in Investor Conference in December
NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that Daniel Vitt, Ph.D., Chief Executive Officer...

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunic, Inc. to Participate in Investor Conference in December )

Also on site :